Showing results (351-360 of 360) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 360 results.
Cancer Epidemiology|January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patientsSinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.
Cancer Medicine|February 13, 2014
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancersKit Man Wong, Xiaoping Qiu, Dangxiao Cheng, et al.
Cancer Medicine|January 12, 2017
Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survivalOlusola O Faluyi, Lawson Eng, Xin Qiu, et al.
JAMA Network Open|October 20, 2025
Faith-Based Lifestyle Intervention for Diabetes Prevention Among Adults in Bangladesh: A Cluster Randomized Clinical TrialBishwajit Bhowmik, Tasnima Siddiquee, Sanjida Binte Munir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.
Emerging Infectious Diseases|January 25, 2008
Person-to-person transmission of Nipah virus in a Bangladeshi communityEmily S Gurley, Joel M Montgomery, M Jahangir Hossain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Clinical presentation of nipah virus infection in BangladeshM Jahangir Hossain, Emily S Gurley, Joel M Montgomery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 TrialGeoffrey Liu, Sinead Cuffe, Shermi Liang, et al.
Human Mutation|May 23, 2009
Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like diseaseAbul Kalam Azad, Robert Rauh, François Vermeulen, et al.
Science Signaling|May 25, 2017
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Styliani Karanika, Guang Yang, et al.
Pageof 36